United Therapeutics Corporation: BTIG raises to buy from neutral
UTHR•BTIG raised its rating on United Therapeutics Corporation to buy from neutral.
Related News
Unicycive Therapeutics appoints Meredith Manning to board of directors
UNCY•
Boeing secures order for first full-rate production Grey Wolf helicopters
BA•
Honda teams with Redwire on space station robotics concept
HMC•
PowerBank shifts Nasdaq listing to Capital Market, wins bid-price extension to March 28, 2027
PBK•
Foghorn Therapeutics expects about 65 employees after reduction
FHTX•